SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001104659-23-080793
Filing Date
2023-07-13
Accepted
2023-07-13 17:00:20
Documents
6
Effectiveness Date
2023-07-13

Document Format Files

Seq Description Document Type Size
1 S-1MEF tm2313083d11_s1mef.htm S-1MEF 36944
2 EXHIBIT 5.1 tm2313083d11_ex5-1.htm EX-5.1 8544
3 EXHIBIT 23.1 tm2313083d11_ex23-1.htm EX-23.1 2528
4 EX-FILING FEES tm2313083d11_ex-filingfees.htm EX-FILING FEES 10984
5 GRAPHIC tm2313083d11_ex5-1img001.jpg GRAPHIC 11429
6 GRAPHIC tm2313083d11_ex5-1img002.jpg GRAPHIC 19380
  Complete submission text file 0001104659-23-080793.txt   102951
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-273236 | Film No.: 231087302
SIC: 2836 Biological Products, (No Diagnostic Substances)